JGB1741

JGB1741
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T22094-1mg 1 mg -

7 - 10 business days*

53.00€
TGM-T22094-5mg 5 mg -

7 - 10 business days*

174.00€
TGM-T22094-1mL 1 ml -

7 - 10 business days*

208.00€
TGM-T22094-10mg 10 mg -

7 - 10 business days*

290.00€
TGM-T22094-25mg 25 mg -

7 - 10 business days*

512.00€
TGM-T22094-50mg 50 mg -

7 - 10 business days*

744.00€
TGM-T22094-100mg 100 mg -

7 - 10 business days*

1,039.00€
 
Description: JGB1741 (ILS-JGB-1741) is a potent and selective inhibitor of SIRT1 with an IC50 of... more
Product information "JGB1741"
Description: JGB1741 (ILS-JGB-1741) is a potent and selective inhibitor of SIRT1 with an IC50 of 15 µM. It modulates the Bax/Bcl2 ratio, cytochrome c release, and PARP cleavage, and increases acetylated p53 levels, leading to p53-mediated apoptosis. JGB1741 can be used in breast cancer studies. Target: Sirtuin. Smiles: Oc1ccc2ccccc2c1\C=N\c1sc2CCCCc2c1C(=O)NCc1ccccc1. References: Arunasree M Kalle, et al. Inhibition of SIRT1 by a small molecule induces apoptosis in breast cancer cells. Biochem Biophys Res Commun. 2010 Oct 8,401(1):13-9.
Keywords: ILS-JGB-1741
Supplier: TargetMol
Supplier-Nr: T22094

Properties

Application: SIRT1 inhibitor
MW: 440.56 D
Formula: C27H24N2O2S

Database Information

CAS : 1256375-38-8| Matching products
KEGG ID : K11411 | Matching products

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "JGB1741"
Write a review
or to review a product.
Viewed